|
Volumn 8, Issue 17, 2009, Pages 2681-2684
|
Met amplification and HSP90 inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE;
AUY 922;
BCR ABL PROTEIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GEFITINIB;
HEAT SHOCK PROTEIN 90 INHIBITOR;
IPI 493;
MPC 3100;
N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE;
PROTEIN KINASE B;
PROTEIN KINASE C EPSILON;
PROTEIN P53;
SCATTER FACTOR RECEPTOR;
SNX 5422;
STA 9090;
TANESPIMYCIN;
UNCLASSIFIED DRUG;
XL 888;
ADVANCED CANCER;
APOPTOSIS;
BREAST CANCER;
CANCER RELAPSE;
CANCER RESISTANCE;
CELL PROLIFERATION;
CELL SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COMPARATIVE GENOMIC HYBRIDIZATION;
GENE DELETION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LYMPHOMA;
NOTE;
PROTEIN BINDING;
SOLID TUMOR;
|
EID: 69749119599
PISSN: 15384101
EISSN: 15514005
Source Type: Journal
DOI: 10.4161/cc.8.17.9475 Document Type: Note |
Times cited : (2)
|
References (7)
|